This study asked whether the cell-surface adhesion molecule NECTIN2 contributes to motility and invasion in triple-negative breast cancer. The team combined public-dataset analyses with stable NECTIN2 depletion in MDA-MB-231 and MDA-MB-468 cells. The major phenotype was confined to MDA-MB-231: migration and invasion fell by about 50%, accompanied by lower LIMK1 and cytoskeletal changes, while LIMK1 re-expression partially restored migration. The findings support a context-dependent mechanism, not a clinically validated drug target or proof that NECTIN2 inhibition prevents metastasis in patients.
Key findings
- Public data showed higher NECTIN2 in breast tumours, and high expression was associated with poorer recurrence-free survival in triple-negative breast cancer: HR 1.41, 95% CI 1.04–1.92, p = 0.025. shRNA reduced NECTIN2 by about 90% in both cell lines without broad cytotoxicity. The survival result is associative, not causal.
- In MDA-MB-231, NECTIN2 depletion reduced 24- and 48-hour wound closure, Transwell migration, and invasion by about 50%. No significant migration or invasion effect was detected in MDA-MB-468.
- LIMK1 mRNA fell by about 70% after NECTIN2 depletion, and GEPIA showed a NECTIN2–LIMK1 correlation of R = 0.48, p < 0.0001. LIMK1 re-expression increased migration in NECTIN2-depleted cells by about 50%, nearly to control levels, whereas invasion rescue was only a non-significant trend.
Why this matters globally
The study adds mechanistic evidence that a cell-surface NECTIN2–LIMK1–cofilin axis may regulate breast-cancer-cell motility in selected contexts, while open data facilitate replication and more patient-relevant validation. Its global potential is hypothesis generation for target validation, not a treatment-ready claim. Clinical impact would require confirmation across additional models, patient specimens, in-vivo metastasis systems, and safety studies of perturbing NECTIN2 or LIMK1.
Thai researcher contribution
All eight authors are affiliated with Mahidol University, linking the Faculty of Medicine Siriraj Hospital with the Institute of Molecular Biosciences. Phatchanat Klaihmon and Phatchariya Phannasil held conceptual, analytical, funding, supervisory, and writing roles; Phatchariya Phannasil is the corresponding author. Funding came from the National Research Council of Thailand, grant N42A680114, and the Mahidol University Strategic Research Fund FY2024, grant MU-SRF-ST-15B/67. The funders had no role in study design, data collection or analysis, publication decisions, or manuscript preparation, according to the article.
Limitations to consider
The evidence is entirely in vitro and strongly cell-line dependent: the phenotype appeared in MDA-MB-231 but not MDA-MB-468, leaving the core mechanism anchored mainly to one responsive model. The study used one shRNA construct, and the 15-gene screen had only two independent biological replicates. It lacks additional TNBC models, patient-derived cells, clinical specimens, in-vivo metastasis studies, and tumour-microenvironment assessment. Database correlations do not establish causality, some upstream signals were measured at mRNA rather than protein-activation level, and LIMK1 re-expression did not significantly rescue invasion.